Phase 2a data supports Protagonist genetic liver disease drug rusfertide
November 15 2021 - 8:00AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Protagonist Therapeutics (NASDAQ:PTGX)
Historical Stock Chart
From Aug 2024 to Sep 2024
Protagonist Therapeutics (NASDAQ:PTGX)
Historical Stock Chart
From Sep 2023 to Sep 2024